[
  {
    "Company": "Orakl Oncology",
    "Model": "Colorectal Cancer Tumor Avatar",
    "Organs/Tissues": "Colorectal tumor (patient-derived 3D organoids)",
    "Physiological/Pathological": "Pathological tumor model",
    "Cell Source": "Primary human colon tumor cells (organoids in ECM)",
    "Multiple Cell Types": "Mainly tumor epithelial cells, optional CAF co-culture",
    "Stromal Cells": "No by default (fibroblasts can be introduced)",
    "Tissue-resident Immune": "No (immune cells typically not retained in expansions)",
    "Circulating Immune": "No (static organoid culture in wells)",
    "Crosstalk (Multi-tissue)": "No, single tumor model",
    "Air-Liquid Interface": "No, submerged 3D organoids",
    "Extracellular Matrix": "Yes (Matrigel or similar hydrogel)",
    "3D Scaffold": "Yes, organoid structure",
    "Notable Features": "Patient-specific heterogeneity, AI-driven drug response predictions",
    "Plate/Format (Throughput)": "Multi-well plate, moderate throughput for drug screening",
    "Max Culture Duration": "Days to a few weeks (organoid viability)",
    "Readouts - Live Imaging": "Yes (fluorescent viability/imaging in wells)",
    "Readouts - Supernatant Sampling": "Yes (secreted factors in media)",
    "Readouts - Cell Retrieval": "Yes (dissociate organoids)",
    "Readouts - Whole Tissue": "Yes (fix organoids for histology)",
    "Readouts - TEER": "No",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No",
    "Dead Volume": "Minimal (small well volumes)",
    "Perfused": "No (static 3D culture)",
    "Gas Mix Controlled": "Standard incubator",
    "Real-time Microenvironment Control": "Manual media/drug changes, no flow",
    "model_availability": "Service only"
  },
  {
    "Company": "Orakl Oncology",
    "Model": "Pancreatic Cancer Tumor Avatar",
    "Organs/Tissues": "Pancreatic tumor (patient-derived 3D organoids)",
    "Physiological/Pathological": "Pathological tumor model",
    "Cell Source": "Primary human pancreatic tumor cells (organoids in ECM)",
    "Multiple Cell Types": "Mainly tumor epithelial, optional fibroblasts",
    "Stromal Cells": "No by default (some stroma can remain or be added)",
    "Tissue-resident Immune": "No (not preserved in expansions)",
    "Circulating Immune": "No (static well format)",
    "Crosstalk (Multi-tissue)": "No",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "Yes (Matrigel/collagen droplet)",
    "3D Scaffold": "Yes, 3D organoid structure",
    "Notable Features": "Patient-specific pancreatic tumor model, AI-based analysis, validated clinically",
    "Plate/Format (Throughput)": "Multi-well plates, moderate throughput",
    "Max Culture Duration": "Days to weeks for drug testing",
    "Readouts - Live Imaging": "Yes (microscopy in wells)",
    "Readouts - Supernatant Sampling": "Yes (collect media for secreted markers)",
    "Readouts - Cell Retrieval": "Yes (organoid dissociation)",
    "Readouts - Whole Tissue": "Yes (histology of organoids)",
    "Readouts - TEER": "No",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No",
    "Dead Volume": "Minimal (static well culture)",
    "Perfused": "No",
    "Gas Mix Controlled": "Incubator environment",
    "Real-time Microenvironment Control": "Manual feeding/compound addition",
    "model_availability": "Service only"
  }
]
